Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

504 public trials 140 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

NCT00849147

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +23 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Diego Medical Center La Jolla, California, United States
  • University of Florida College of Medicine (Shands) Gainesville, Florida, United States
  • Bone Marrow Transplant Group of Georgia, Northside Hospital Atlanta, Georgia, United States
View all 17 locations
View Trial Details
Completed

Autologous Transplant in HIV Patients (BMT CTN 0803)

NCT01141712

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Diego Medical Center La Jolla, California, United States
  • UCLA Los Angeles, California, United States
  • University of CA, SF San Francisco, California, United States
View all 16 locations
View Trial Details
Completed

A Phase II Study of the FIL on Elderly Frail Patients With DLBCL

NCT02955823

Conditions
Diffuse Large B-cells Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) - Ematologia Meldola, Forlì-Cesena, Italy
  • A.O. C. Panico - U.O.C Ematologia e Trapianto Tricase, Lecce, Italy
  • Azienda Ospedaliera Arcispedale Santa Maria Nuova - IRCCS - Ematologia Reggio Emilia, Italy
  • Ospedale Dell'Angelo - U.O. Ematologia Mestre, Venezia, Italy
View all 18 locations
View Trial Details
Completed

Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma With EZH2 Gene Mutation

NCT03456726

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • 1004 Eisai Trial Site Nagoya, Aichi-ken, Japan
  • 1029 Eisai Trial Site Nagoya, Aichi-ken, Japan
  • 1020 Eisai Trial Site Ōta, Gunma, Japan
  • 1007 Eisai Trial Site Sapporo, Hokkaido, Japan
View all 28 locations
View Trial Details
Completed

Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)

NCT00864227

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +23 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of Florida College of Medicine, Shands Gainesville, Florida, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
View all 16 locations
View Trial Details
Completed

Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT01647971

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +33 more
Locations
  • TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
  • TG Therapeutics Investigational Trial Site Jonesboro, Arkansas, United States
  • TG Therapeutics Investigational Trial Site Athens, Georgia, United States
  • TG Therapeutics Investigational Trial Site Macon, Georgia, United States
View Trial Details
Completed

Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma

NCT03682796

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions